Thomas Kendrick
| Year | University | Degree |
|---|---|---|
| 2020 | Northwestern University - Feinberg School of Medicine | NRSA Postdoctoral Fellow |
| 2017 | Louisiana State University Health Sciences Center | Ph.D. Microbiology & Immunology - Minor: Biochemistry |
| 2009 | California Polytechnic University | B.Sc. Microbiology - Minor: English |
My lab focuses on two areas of research: 1) understanding how viruses co-opt ribosomal proteins to promote viral protein synthesis; and 2) understanding how viruses subvert the innate immune response to promote viral replication. I say “viruses” because my projects have evolved to include several virus families. If you are interested in any specific projects, please contact me to discuss. I am open to any new collaborations if you are interested in studying viruses, especially in a new context. If you are a student interested in virus research, reach out to me to discuss possible research opportunities.
2024 – 2025 FY25 One Health Program (Co-PI)
2024 – 2026 2024 AOA OMM Observational & Explorative Focused Hypotheses Research Studies (PI)
2024 – 2027 NIH Research Enhancement Award (R15) in Oncological Sciences (Co-I)
2023 – 2024 FY24 Research Eureka Accelerator Program (REAP) (Co-PI)
2022 – 2023 FY23 Research Eureka Accelerator Program (REAP) (Co-PI)
2022 – 2023 Delta Collaborative Research Project (Delta-CRP) (Co-PI)
2022 – 2024 LSUHS NIH NIGMS COBRE Pilot Project Recipient (PI)
2021 – 2022 FY22 Research Eureka Accelerator Program (REAP) (PI)
2019 – 2021 NIH Extramural Loan Repayment Program for Pediatric Research (PI)
Our lab’s research interests center around injury and repair mechanisms critical to pulmonary endothelial cell function. Major areas of focus include nosocomial pneumonia, acute respiratory distress syndrome, and acute lung injury. We (Drs. Sarah Voth and Rebekah Morrow) are focusing on endothelial cell injury and disease propagation where we employ Pseudomonas aeruginosa, a leading cause of nosocomial pneumonia, to uncover cell damage and repair mechanisms in acute lung injury. In our lab, we routinely use mammalian and bacterial culture, microscopy, western blot, RT-PCR, ELISA, colony formation, migration, and invasion assays. We are actively looking to recruit students into the lab, and the majority of our work will be conducted in the University of Louisiana Monroe School of Pharmacy.
Our lab’s research interests center around injury and repair mechanisms critical to pulmonary endothelial cell function. Major areas of focus include pulmonary arterial hypertension (PAH), acute respiratory distress syndrome, and acute lung injury. Continuing my previous experience in graduate school with pulmonary endothelial cells and my focus on immune responses/inflammation, we have begun to study molecular mechanisms that contribute to PAH, such as the Endothelial-to-Mesenchymal transition (EndMT). In a second project, we are focusing on endothelial cell injury and disease propagation where we employ Pseudomonas aeruginosa, a leading cause of nosocomial pneumonia, to uncover cell damage and repair mechanisms in acute lung injury. In our lab, we routinely use mammalian and bacterial culture, microscopy, western blot, RT-PCR, ELISA, colony formation, migration, and invasion assays. We are actively looking to recruit students into the lab, and the majority of our work will be conducted in the University of Louisiana Monroe School of Pharmacy.